Rethinking the reasons to treat atrial fibrillation? The role of dronedarone in reducing cardiovascular hospitalizations

Eur Heart J. 2009 Oct;30(20):2438-40. doi: 10.1093/eurheartj/ehp381. Epub 2009 Sep 10.

Authors

Rodney H Falk¹, A John Camm

Affiliation

¹ Department of Cardiology, Harvard Vanguard Medical Associates, Boston, MA 02215, USA. rfalk@partners.org

PMID: 19744955
DOI: 10.1093/eurheartj/ehp381

No abstract available

MeSH terms

Amiodarone / analogs & derivatives*
Amiodarone / therapeutic use
Anti-Arrhythmia Agents / therapeutic use*
Atrial Fibrillation / drug therapy*
Atrial Fibrillation / mortality
Clinical Trials as Topic
Dronedarone
Hospitalization*
Humans
Risk Factors

Substances

Anti-Arrhythmia Agents
Dronedarone
Amiodarone